Taribavirin is an oral, liver-targeting inhibitor of inosine monophosphate dehydrogenase (IMPDH) developed for hepatitis C virus (HCV) research. Its design aims to minimize red blood cell distribution, thereby reducing the risk of hemolytic anemia in experimental models, making it a tool for studying antiviral mechanisms in vitro and in vivo.
Molecular Weight:
243.22
CAS Number:
[119567-79-2]
Formula:
C8H13N5O4
Target:
HCV Protease,Others,HBV
* VAT and and shipping costs not included. Errors and price changes excepted